← Open Payments lookup

FARIS TAHSIN: Open Payments

NPI 1255836672 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,838 in 132 payments from 17 companies in 2025. Trend: 2023 $313 · 2024 $1,576 · 2025 $2,838

Food & beverage: $2,838
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$625
Otsuka America Pharmaceutical, Inc.25$418
E.R. Squibb & Sons, L.L.C.12$284
Alkermes, Inc.9$240
Teva Pharmaceuticals USA, Inc.11$237
Janssen Pharmaceuticals, Inc9$199
ABBVIE INC.10$161
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$152
Vanda Pharmaceuticals Inc.4$120
Axsome Therapeutics, Inc.5$111

Products named: INGREZZA, REXULTI, COBENFY, ARISTADA, VRAYLAR, AUSTEDO XR, CAPLYTA, SPRAVATO.

Industry payments across NV — which companies pay providers there.